{
    "Trade/Device Name(s)": [
        "RNA1c Hemoglobin A1c Control for Bayer DCA2000 and DCA2000+ Analyzers",
        "RNA1c Control for Bayer DCA2000 and DCA2000+ Analyzers"
    ],
    "Submitter Information": "Bionostics, Inc.",
    "510(k) Number": "K050100",
    "Predicate Device Reference 510(k) Number(s)": [
        "K021484",
        "K940971"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "February 25, 2005",
    "Summary Letter Received Date": "January 18, 2005",
    "Submission Date": "January 17, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glycated hemoglobin (HbA1c%)"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [
        "Plastic bottle with dropper tip"
    ],
    "Instrument(s)/Platform(s)": [
        "Bayer DCA2000 Analyzer",
        "Bayer DCA2000+ Analyzer"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for RNA1c Hemoglobin A1c Control as an aqueous solution for quality control on Bayer DCA2000 and DCA2000+ Analyzers.",
    "Indications for Use Summary": "Intended to monitor and evaluate the analytical performance of Bayer DCA2000 and DCA2000+ Analyzers that measure HbA1c, providing objective assessment of precision within clinically important range.",
    "fda_folder": "Clinical Chemistry"
}